WDFY3 and esophageal cancer: Taken WDFY3‐AS2, RP11‐51F16.1, AC016738.4, and AC092168.2, for example, esophageal cancer patients with higher WDFY3‐AS2 and RP11‐51F16.1 expression levels had shorter OS time, while esophageal cancer patients with higher AC016738.4 and AC092168.2 expression levels had shorter RFS time (Figure 3B,C).